Case Studies

Comprehensive Assessment Leads to FDA Alignment

By September 3, 2026September 11th, 2026No Comments
Pharmaceutical manufacturing equipment in a cleanroom

A biosimilar sponsor engaged Pharmatech for process development and validation planning. We aligned their cell bank characterization strategy, authored development plans, and guided contract testing.

Impact for the client:

  • Biosimilarity successfully demonstrated
  • Robust control strategy established
  • FDA alignment achieved without delays
Skip to content